Putting COVID’s Lessons Into Practice
A lot is on the European political table for 2022. it goes from building the European Health Union to fighting antimicrobial resistance. All eyes are on the newest COVID-19 virus variant Omicron, which made world leaders rethink sanitary measures and showed that vaccination alone is not enough.
Furthermore, it is also a reminder of the importance of getting vaccinated to avoid mutations. “No one is safe until everyone is safe” – the famous slogan is proving itself right once again.
“No one is safe until everyone is safe”
But despite knowing that the longer virus circulates, the more mutations we can expect, only 8% of people in low-income countries have received at least one dose. In comparison, in the EU, this figure is nine times higher at 73%.
To solve the issue, South Africa and India proposed suspending intellectual property rights for COVID-19 treatments and vaccines to the World Trade Organisation in October 2020, arguing that it could speed up vaccine access in poorer countries. However, due to the new COVID variant, the proposal has not yet been discussed.
For more information about Pharmaceuticals, in vitro, digital health, new vaccines and treatments read the full Euractiv article.